Pharmacy news

• AHF Welcomes Reforms in H.R. 7148 Targeting Pharmacy Benefit Managers - AIDS Healthcare Foundation

  22-01-2026 23:35
  AHF Welcomes Reforms in H.R. 7148 Targeting Pharmacy Benefit Managers  AIDS Healthcare Foundation
  
  Read more

• Cigna Sees Up to $600 Million Earnings Hit From Pharmacy Plan - Bloomberg.com

  22-01-2026 23:32
  Cigna Sees Up to $600 Million Earnings Hit From Pharmacy Plan  Bloomberg.com
  
  Read more

• A Successful Model for Managing Pulmonary Arterial Hypertension

  22-01-2026 18:23 via pharmacypracticenews.com
  Originally published by our sister publication Specialty Pharmacy ContinuumBy Gina ShawSpecialty pharmacists embedded in a pulmonary arterial hypertension (PAH) clinic significantly improved management of side effects and boosted treatment adherence, according to new data presented at the NASP 2025 Annual Meeting & Expo, in Denver.Researchers from the Medical University of South Carolina (MUSC) evaluated interventions for 62 patients treated between January 2024 and April 2025 (poster OPR32-
  
  Read more

• A-Successful-Model-for-Managing-Pulmonary-Arterial-Hypertension

  22-01-2026 18:23 via pharmacypracticenews.com
  Originally published by our sister publication Specialty Pharmacy ContinuumBy Gina ShawSpecialty pharmacists embedded in a pulmonary arterial hypertension (PAH) clinic significantly improved management of side effects and boosted treatment adherence, according to new data presented at the NASP 2025 Annual Meeting & Expo, in Denver.Researchers from the Medical University of South Carolina (MUSC) evaluated interventions for 62 patients treated between January 2024 and April 2025 (poster OPR32-
  
  Read more

• Advertisement

• People’s Pharmacy: Doesn’t testosterone replacement therapy contribute to risk of heart attacks and cancer? - oregonlive.com

  22-01-2026 17:48
  People’s Pharmacy: Doesn’t testosterone replacement therapy contribute to risk of heart attacks and cancer?  oregonlive.com
  
  Read more

• Secondary Immunodeficiency: A Growing Healthcare Concern

  22-01-2026 17:45 via pharmacypracticenews.com
  Antoine Azar, MDAssociate Professor of Clinical MedicineDivision of Allergy and Clinical ImmunologyJohns Hopkins University School of MedicineBaltimore, MarylandAmy E. Clarke, DNP, RN, IgCN®Chief Clinical OfficerImmunoglobulin National SocietyCalabasas, CaliforniaLuba Sobolevsky, PharmD, IgCP®President and CEOImmunoglobulin National SocietyCalabasas, CaliforniaThe immune system plays a central role in protecting the body against infections, malignancies, and abnormal inflammatory respons
  
  Read more

• Secondary-Immunodeficiency-A-nbsp-Growing-Healthcare-Concern

  22-01-2026 17:45 via pharmacypracticenews.com
  Antoine Azar, MDAssociate Professor of Clinical MedicineDivision of Allergy and Clinical ImmunologyJohns Hopkins University School of MedicineBaltimore, MarylandAmy E. Clarke, DNP, RN, IgCN®Chief Clinical OfficerImmunoglobulin National SocietyCalabasas, CaliforniaLuba Sobolevsky, PharmD, IgCP®President and CEOImmunoglobulin National SocietyCalabasas, CaliforniaThe immune system plays a central role in protecting the body against infections, malignancies, and abnormal inflammatory respons
  
  Read more

• Caring for Pediatric Patients With Difficult-to-Treat IBD

  22-01-2026 15:54 via pharmacypracticenews.com
  By Katie PrinceTreating younger patients with inflammatory bowel disease (IBD) can be particularly challenging, with considerations such as off-label treatments, concerns about how treatment will affect growth, and the need for shared decision-making that includes patients as well as their parents.Athos Bousvaros, MD, MPH, a professor of pediatrics at Harvard Medical School and the associate director of the IBD Center at Boston Children’s Hospital, gave a presentation about how he approach
  
  Read more

• Advertisement

• 4 New Oncology Drugs Poised to Transform Cancer Care

  22-01-2026 15:53 via pharmacypracticenews.com
  By Cynthia E. KeenIn 2024, the FDA’s Center for Drug Evaluation and Research approved 16 novel cancer drugs. The pace of approvals has remained brisk throughout 2025, with 13 novel oncology drugs cleared as of mid-October.“In addition to new FDA-approved drugs, the National Comprehensive Cancer Network issues updates of practice guidelines. So how are you to keep up with all of this information?” Mark Pegram, MD, a professor of medical oncology at the Stanford University School
  
  Read more

• Health-System Specialty Pharmacy Innovation and Models of Care

  22-01-2026 15:52 via pharmacypracticenews.com
  By Gina Shaw Connie Vo, PharmDFor health-system specialty pharmacies (HSSPs), innovation is key to keeping their model and services viable amid shifting reimbursement and shrinking margins, the complexities of patient onboarding, site-of-care restrictions, and patient access challenges.In a session at the NASP 2025 Annual Meeting & Expo, in Denver, HSSP leaders described how they are rethinking workforce, access services, and technology to adapt their models of care.UW Health: Leveraging AI
  
  Read more

• Adherence, Rx Outcomes on Wish List for SP Benchmarking Standards

  22-01-2026 15:51 via pharmacypracticenews.com
  By Gina Shaw Karen C. Thomas, PharmDSpecialty pharmacies are drowning in data, collecting and reporting dozens of disparate measures to meet the requirements of internal teams, payors, manufacturers and accrediting bodies.But not enough of these metrics are applied consistently to evaluate pharmacy performance or guide clinical decision-making, according to a team of specialty pharmacy outcomes experts at Vanderbilt University Medical Center, in Nashville, Tennessee.“We collect all of thes
  
  Read more

• Transitioning Rh Immune Globulin Oversight to Pharmacy Improves Safety, Timeliness, and Consistency

  22-01-2026 15:49 via pharmacypracticenews.com
  By Gina ShawTransitioning oversight of Rho(D) immune globulin (RhIG) from the blood bank to the pharmacy led to improved safety, timeliness, and standardization of postpartum dosing, according to new data presented at the ASHP 2025 Midyear Clinical Meeting & Exhibition, in Las Vegas.RhIG, a biologic used to prevent Rh alloimmunization in pregnancy, has long occupied a regulatory gray zone. Although the FDA categorizes it under “blood and biologics,” some organizations handle it a
  
  Read more

• Pharmacists Can Be Key Players in Patients’ Life-Altering CGT Journeys

  22-01-2026 15:41 via pharmacypracticenews.com
  Originally published by our sister publication Specialty Pharmacy ContinuumBy Karen BlumFor more than 30 years, Taylor John experienced debilitating pain crises from sickle cell disease that frequently sent her to the hospital. Last year—following two injections of gene therapy in 30 minutes—she became pain-free.Such life-changing experiences represent the future of pharmacy, said Kim Tedesco, RPh, the director of gene and cell operations at Walgreens, during a presentation at the NA
  
  Read more

• 62-year-old retail pharmacy chain makes unusual closure decision - thestreet.com

  22-01-2026 15:28
  62-year-old retail pharmacy chain makes unusual closure decision  thestreet.com
  
  Read more

• HSSPs Find Time Savings in Automation, Digital Access

  22-01-2026 15:25 via pharmacypracticenews.com
  By Gina ShawAs health-system specialty pharmacies look to expand services without growing their head count, some are finding that small automation tools can deliver outsized results. At the NASP 2025 Annual Meeting & Expo, in Denver, presenters described how targeted digital fixes are freeing staff time and improving patient communication.At Emory Healthcare in Atlanta, automation now handles routine electronic dispensing and refill tasks once managed manually by technicians. A new auto-pay
  
  Read more

• HSSPs-Find-Time-Savings-in-Automation-Digital-Access

  22-01-2026 15:25 via pharmacypracticenews.com
  By Gina ShawAs health-system specialty pharmacies look to expand services without growing their head count, some are finding that small automation tools can deliver outsized results. At the NASP 2025 Annual Meeting & Expo, in Denver, presenters described how targeted digital fixes are freeing staff time and improving patient communication.At Emory Healthcare in Atlanta, automation now handles routine electronic dispensing and refill tasks once managed manually by technicians. A new auto-pay
  
  Read more

• Pharmacists Boost Quality of RhIG Oversight

  22-01-2026 14:28 via pharmacypracticenews.com
  By Gina ShawTransitioning oversight of Rho(D) immune globulin (RhIG) from the blood bank to the pharmacy led to improved safety, timeliness, and standardization of postpartum dosing, according to new data presented by investigators from University Hospitals Cleveland Medical Center.At University Hospitals, RhIG was historically dispensed through the blood bank using a paper-based process submitted by the provider to the blood bank, explained presenting author Rebecca Powell, PharmD, BCPS, a clin
  
  Read more

• Pharmacists-Boost-Quality-of-RhIG-Oversight

  22-01-2026 14:28 via pharmacypracticenews.com
  By Gina ShawTransitioning oversight of Rho(D) immune globulin (RhIG) from the blood bank to the pharmacy led to improved safety, timeliness, and standardization of postpartum dosing, according to new data presented by investigators from University Hospitals Cleveland Medical Center.At University Hospitals, RhIG was historically dispensed through the blood bank using a paper-based process submitted by the provider to the blood bank, explained presenting author Rebecca Powell, PharmD, BCPS, a clin
  
  Read more

• 3 New COPD Treatments Breathe New Life Into a Chronic Disease

  22-01-2026 14:28 via pharmacypracticenews.com
  By Marcus A. BanksAfter several decades without new treatment options for chronic obstructive pulmonary disease (COPD), three new drugs gained FDA approval over the past two years: the biologics dupilumab (Dupixent, Sanofi and Regeneron) and mepolizumab (Nucala, GlaxoSmithKline) and inhaled ensifentrine (Ohtuvayre, Verona).“This is exciting. We’ve mostly been using the same medications to treat COPD for the last 20 or 30 years,” said Nathan Pinner, PharmD, a clinical professor
  
  Read more

• 3-New-COPD-Treatments-Breathe-New-Life-Into-a-Chronic-Disease

  22-01-2026 14:28 via pharmacypracticenews.com
  By Marcus A. BanksAfter several decades without new treatment options for chronic obstructive pulmonary disease (COPD), three new drugs gained FDA approval over the past two years: the biologics dupilumab (Dupixent, Sanofi and Regeneron) and mepolizumab (Nucala, GlaxoSmithKline) and inhaled ensifentrine (Ohtuvayre, Verona).“This is exciting. We’ve mostly been using the same medications to treat COPD for the last 20 or 30 years,” said Nathan Pinner, PharmD, a clinical professor
  
  Read more

• Restoring Immune Homeostasis In Long COVID

  22-01-2026 14:27 via pharmacypracticenews.com
  Amy E. Clarke, DNP, RN, IgCN®Chief Clinical OfficerImmunoglobulin National SocietyCalabasas, CaliforniaLuba Sobolevsky, PharmD, IgCP®President and CEOImmunoglobulin National SocietyCalabasas, CaliforniaPost-acute sequelae of SARS-CoV-2 infection (PASC, commonly referred to as long COVID) has emerged as a chronic multisystem consequence of the COVID-19 pandemic, representing a growing clinical and societal burden. It affects an estimated 1 in 3 survivors worldwide, with symptoms in 36% of
  
  Read more

• Restoring-Immune-Homeostasis-In-Long-COVID

  22-01-2026 14:27 via pharmacypracticenews.com
  Amy E. Clarke, DNP, RN, IgCN®Chief Clinical OfficerImmunoglobulin National SocietyCalabasas, CaliforniaLuba Sobolevsky, PharmD, IgCP®President and CEOImmunoglobulin National SocietyCalabasas, CaliforniaPost-acute sequelae of SARS-CoV-2 infection (PASC, commonly referred to as long COVID) has emerged as a chronic multisystem consequence of the COVID-19 pandemic, representing a growing clinical and societal burden. It affects an estimated 1 in 3 survivors worldwide, with symptoms in 36% of
  
  Read more

• Novel Agents in Metastatic Non–Small Cell Lung Cancer

  22-01-2026 14:26 via pharmacypracticenews.com
  Laura Koppen, PharmD, BCPSClinical Assistant ProfessorDrug Information SpecialistUniversity of Illinois Chicago, Retzky College of PharmacyLung cancer affects more than 200,000 people in the United States annually; non–small cell lung cancer (NSCLC) accounts for approximately 85% of all lung cancer cases.1-3 Lung cancer is the leading cause of cancer-related mortality in the United States, responsible for more than 120,000 deaths each year. In many cases, NSCLC is not diagnosed until dista
  
  Read more

• How Health Systems Are Preparing for the CAR-T Surge

  22-01-2026 14:26 via pharmacypracticenews.com
  By Gina ShawOnce reserved for small cohorts of patients with relapsed or refractory blood cancers, chimeric antigen receptor T-cell (CAR-T) therapy is now expanding rapidly, with multiple products approved across lymphomas, leukemias, and myeloma, and a robust pipeline targeting solid tumors. A recent review of the CAR-T landscape (Signal Transduct Target Ther 2025;10[1]:210) called it “the culmination of decades of immunology and genetic engineering research,” while cautioning that
  
  Read more

• Breast Cancer Primer, New Treatments, and Supportive Care

  22-01-2026 14:25 via pharmacypracticenews.com
  Rachel Brunner, PharmD, BCPSClinical Assistant Professor, College of PharmacyClinical Pharmacist, Drug Information GroupUniversity of Illinois Chicago, Retzky College of PharmacyBreast cancer is the most common cancer in women in the United States.1,2 It is second to lung cancer as a cause of cancer death in this population.2 In 2022, there was estimated to be more than 4 million women in the US living with breast cancer.1 The goal of breast cancer treatment is to effectively manage the disease
  
  Read more

• How Specialty Pharmacists Can Keep HIV Patients on ART

  22-01-2026 14:24 via pharmacypracticenews.com
  Originally published by our sister publication Specialty Pharmacy ContinuumBy Fran KritzA team of specialty pharmacists and pharmacy liaisons in Brooklyn successfully transitioned a small group of patients living with HIV from daily oral antiviral therapy (ART) to injectable long-acting antiretroviral therapy (LA-ART). The switch improved medication access and adherence, and optimized treatment outcomes for HIV management and PrEP, the team reported at the NASP 2025 Annual Meeting & Expo, in
  
  Read more

• Pharmacist-Led Education Improves ED Tdap Stewardship

  22-01-2026 13:11 via pharmacypracticenews.com
  By Ethan CoveyA pharmacist-led educational initiative significantly reduced unnecessary Tdap (tetanus, diphtheria, and pertussis) vaccinations in the emergency department (ED) and improved the use of Florida’s immunization registry for verifying vaccination history, according to new data.“What initially sparked this project was recognizing how frequently Tdap was being administered in the ED without reliable verification of the patient’s vaccination history,” said present
  
  Read more

• Pharmacist-Led-Education-Improves-ED-Tdap-Stewardship

  22-01-2026 13:11 via pharmacypracticenews.com
  By Ethan CoveyA pharmacist-led educational initiative significantly reduced unnecessary Tdap (tetanus, diphtheria, and pertussis) vaccinations in the emergency department (ED) and improved the use of Florida’s immunization registry for verifying vaccination history, according to new data.“What initially sparked this project was recognizing how frequently Tdap was being administered in the ED without reliable verification of the patient’s vaccination history,” said present
  
  Read more

• Myth-Busters:

  22-01-2026 13:07 via pharmacypracticenews.com
  Jerry Siegel, PharmD, FASHPClinical Associate ProfessorCollege of PharmacyThe Ohio State UniversityColumbusAfter 5,000 years, rabies is still nearly 100% fatal, but deaths can be prevented with proper administration of post-exposure prophylaxis (PEP). In a 2022 article by Whitehouse et al, the authors noted that there were 122 breakthrough rabies infections when PEP was given due to 4 factors: 1) deviations from core practice; 2) delays in seeking healthcare; 3) errors in administration of human
  
  Read more

• Myth-Busters

  22-01-2026 13:07 via pharmacypracticenews.com
  Jerry Siegel, PharmD, FASHPClinical Associate ProfessorCollege of PharmacyThe Ohio State UniversityColumbusAfter 5,000 years, rabies is still nearly 100% fatal, but deaths can be prevented with proper administration of post-exposure prophylaxis (PEP). In a 2022 article by Whitehouse et al, the authors noted that there were 122 breakthrough rabies infections when PEP was given due to 4 factors: 1) deviations from core practice; 2) delays in seeking healthcare; 3) errors in administration of human
  
  Read more

• 4 Types of Burnout and Tips for Beating Them

  22-01-2026 13:04 via pharmacypracticenews.com
  By Karen BlumBurnout can be divided into four distinct categories, and understanding the nuances of each can help pharmacy leaders develop strategies to address this ongoing workplace challenge, a speaker said at the 2025 ASHP Pharmacy Futures meeting, in Charlotte, North Carolina.Marco - stock.adobe.comWith some 28% of the global workforce very often reporting feelings of burnout (according to McKinsey & Co.; bit.ly/3WVuSVh), resulting in people being 2.3 times more likely to leave their jo
  
  Read more

• 4-Types-of-Burnout-and-Tips-for-Beating-Them

  22-01-2026 13:04 via pharmacypracticenews.com
  By Karen BlumBurnout can be divided into four distinct categories, and understanding the nuances of each can help pharmacy leaders develop strategies to address this ongoing workplace challenge, a speaker said at the 2025 ASHP Pharmacy Futures meeting, in Charlotte, North Carolina.Marco - stock.adobe.comWith some 28% of the global workforce very often reporting feelings of burnout (according to McKinsey & Co.; bit.ly/3WVuSVh), resulting in people being 2.3 times more likely to leave their jo
  
  Read more

• 2026 Will Bring a Blizzard of Payment Changes—and Opportunities

  22-01-2026 12:53 via pharmacypracticenews.com
  Bonnie Kirschenbaum, MS, FASHP,FCSHP“Reimbursement Matters” is a tool for maintaining your health system’s fiscal health. Please email the author at [email protected] with suggestions on reimbursement issues that you would like to see covered.Source: Bonnie Kirschenbaum, MS, FASHP, FCSHPBeing complicit means being involved in, or having knowledge of, a wrongdoing or an omission. When healthcare is in a financial crisis and drugs and biologicals are a key component, i
  
  Read more

• 2026-Will-Bring-a-Blizzard-of-Payment-Changes—and-Opportunities

  22-01-2026 12:53 via pharmacypracticenews.com
  Bonnie Kirschenbaum, MS, FASHP,FCSHP“Reimbursement Matters” is a tool for maintaining your health system’s fiscal health. Please email the author at [email protected] with suggestions on reimbursement issues that you would like to see covered.Source: Bonnie Kirschenbaum, MS, FASHP, FCSHPBeing complicit means being involved in, or having knowledge of, a wrongdoing or an omission. When healthcare is in a financial crisis and drugs and biologicals are a key component, i
  
  Read more

• ADC Insights From ASHP Midyear

  22-01-2026 12:50 via pharmacypracticenews.com
  By Marcus A. BanksTwo presentations at the ASHP Midyear 2025 Clinical Meeting & Exhibition, in Las Vegas, highlighted medication safety improvements related to automated dispensing cabinets (ADCs). One poster (4-034) demonstrated that implementing ADC safeguards—and increased pharmacist oversight—in the emergency department (ED) slashed override rates to below 3%. The other poster (4-062) featured a streamlined process for inventorying controlled substances stored in the ADC.Bapt
  
  Read more

• ADC-Insights-From-ASHP-Midyear

  22-01-2026 12:50 via pharmacypracticenews.com
  By Marcus A. BanksTwo presentations at the ASHP Midyear 2025 Clinical Meeting & Exhibition, in Las Vegas, highlighted medication safety improvements related to automated dispensing cabinets (ADCs). One poster (4-034) demonstrated that implementing ADC safeguards—and increased pharmacist oversight—in the emergency department (ED) slashed override rates to below 3%. The other poster (4-062) featured a streamlined process for inventorying controlled substances stored in the ADC.Bapt
  
  Read more

• Bluesight Report: Hospitals Step Up Diversion Surveillance

  22-01-2026 12:47 via pharmacypracticenews.com
  By Gina ShawHospitals are investing more deeply in both people and technology to combat controlled substance diversion, according to the Bluesight 2025 Diversion Trends Report, which analyzed more than 266 million controlled substance transactions across 1,159 hospitals (bit.ly/47LGBMn).The data show steady improvement in documentation compliance, with the share of controlled substance transactions containing variances dropping from 7% to 6% between 2023 and 2024. That represents 2.6 million add
  
  Read more

• Bluesight-Report-Hospitals-Step-Up-Diversion-Surveillance

  22-01-2026 12:47 via pharmacypracticenews.com
  By Gina ShawHospitals are investing more deeply in both people and technology to combat controlled substance diversion, according to the Bluesight 2025 Diversion Trends Report, which analyzed more than 266 million controlled substance transactions across 1,159 hospitals (bit.ly/47LGBMn).The data show steady improvement in documentation compliance, with the share of controlled substance transactions containing variances dropping from 7% to 6% between 2023 and 2024. That represents 2.6 million add
  
  Read more

• Artificial Intelligence Boosts PA Submissions

  22-01-2026 12:44 via pharmacypracticenews.com
  By Marcus A. BanksArtificial intelligence enhanced the prior authorization (PA) process for a health system in Ohio, per pilot research presented at the NASP 2025 Annual Meeting & Expo, in Denver (PSP91-RP).In the project, AI streamlines the workflow for PA coordinators, said pilot leader Dylan McWilliams, PharmD, the PGY2 Specialty Pharmacy Administration and Leadership resident at The Ohio State University Wexner Medical Center, in Columbus.The pilot is a three-way effort between Ohio Stat
  
  Read more

• Artificial-Intelligence-Boosts-PA-Submissions

  22-01-2026 12:44 via pharmacypracticenews.com
  By Marcus A. BanksArtificial intelligence enhanced the prior authorization (PA) process for a health system in Ohio, per pilot research presented at the NASP 2025 Annual Meeting & Expo, in Denver (PSP91-RP).In the project, AI streamlines the workflow for PA coordinators, said pilot leader Dylan McWilliams, PharmD, the PGY2 Specialty Pharmacy Administration and Leadership resident at The Ohio State University Wexner Medical Center, in Columbus.The pilot is a three-way effort between Ohio Stat
  
  Read more

• Remdesivir Criteria Save $500K-Plus Without Affecting Outcomes

  22-01-2026 12:41 via pharmacypracticenews.com
  By Ethan CoveyA systemwide shift to more restrictive remdesivir (Veklury, Gilead Sciences) eligibility criteria led to a substantial reduction in drug use and associated costs—without worsening clinical outcomes—according to a retrospective analysis.“This study was inspired by the rapidly changing dynamics of hospitalized COVID-19 care nationwide and the lack of evidence regarding the use of remdesivir in the later Omicron era,” said presenting author James Nicholson, Pha
  
  Read more

• Remdesivir-Criteria-Save-500K-Plus-Without-Affecting-Outcomes

  22-01-2026 12:41 via pharmacypracticenews.com
  By Ethan CoveyA systemwide shift to more restrictive remdesivir (Veklury, Gilead Sciences) eligibility criteria led to a substantial reduction in drug use and associated costs—without worsening clinical outcomes—according to a retrospective analysis.“This study was inspired by the rapidly changing dynamics of hospitalized COVID-19 care nationwide and the lack of evidence regarding the use of remdesivir in the later Omicron era,” said presenting author James Nicholson, Pha
  
  Read more

• PCR-Based MRSA Nasal Screening a Stewardship Success

  22-01-2026 12:37 via pharmacypracticenews.com
  By Ethan CoveySwitching from culture-based to PCR-based methicillin-resistant Staphylococcus aureus (MRSA) nasal screening can help better support patients on anti-MRSA therapy, according to a new study.The researchers found that polymerase chain reaction (PCR) testing led to substantially faster de-escalation of anti-MRSA therapy for hospitalized pneumonia patients across CHI Health facilities, in Omaha, Nebraska.The multicenter retrospective analysis (abstract 8-074) included 200 hospitalized
  
  Read more

• PCR-Based-MRSA-Nasal-Screening-a-Stewardship-Success

  22-01-2026 12:37 via pharmacypracticenews.com
  By Ethan CoveySwitching from culture-based to PCR-based methicillin-resistant Staphylococcus aureus (MRSA) nasal screening can help better support patients on anti-MRSA therapy, according to a new study.The researchers found that polymerase chain reaction (PCR) testing led to substantially faster de-escalation of anti-MRSA therapy for hospitalized pneumonia patients across CHI Health facilities, in Omaha, Nebraska.The multicenter retrospective analysis (abstract 8-074) included 200 hospitalized
  
  Read more

• Outpatient Pharmacists Lead Refill Management at University Hospitals

  22-01-2026 12:02 via pharmacypracticenews.com
  By Marcus A. BanksOutpatient pharmacists can lead medication refill management for ambulatory patients, speeding medication access while boosting provider satisfaction, according to a presentation by Richie Romaniszyn, PharmD.Dr. Romaniszyn is an operations coordinator at University Hospitals in Cleveland, where some pharmacists have approved access to electronic communications between patients and providers. “A pharmacist could catch things a provider may not, like a drug–drug inter
  
  Read more

• Clearing-the-Cleanroom-Storm-Clouds

  22-01-2026 11:57 via pharmacypracticenews.com
  By Gina ShawKevin Hansen, PharmDVisual inspection in sterile compounding is misunderstood, underperformed, and overdue for serious attention, warned two leading compounding experts at the ASHP Midyear 2025 Clinical Meeting & Exhibition, in Las Vegas.“Many compounders think they’re performing a visual inspection,” said Kevin Hansen, PharmD, BCSCP, the senior director of pharmacy compounding services at Premier Inc. “But when they describe what they’re actually do
  
  Read more

• Great Clinical Pharmacists Can Make Exceptional Leaders—If They Act Now

  22-01-2026 11:54 via pharmacypracticenews.com
  By Michael Kleinschmidt, PharmD, MBA, FACHE, CPEL, DPLAWhen pharmacists think about their career trajectory, they often imagine a path anchored firmly within the pharmacy department: clinical practice, perhaps management, maybe a system-level oversight role. Rarely do we picture pharmacists in the chief operating/executive seat—not because we aren’t capable, but because the profession hasn’t historically framed the clinical pharmacist as an executive-in-training.Yet as I advanc
  
  Read more

• Great-Clinical-Pharmacists-Can-Make-Exceptional-Leaders—If-They-Act-Now

  22-01-2026 11:54 via pharmacypracticenews.com
  By Michael Kleinschmidt, PharmD, MBA, FACHE, CPEL, DPLAWhen pharmacists think about their career trajectory, they often imagine a path anchored firmly within the pharmacy department: clinical practice, perhaps management, maybe a system-level oversight role. Rarely do we picture pharmacists in the chief operating/executive seat—not because we aren’t capable, but because the profession hasn’t historically framed the clinical pharmacist as an executive-in-training.Yet as I advanc
  
  Read more

• Technology Can Help Boost HSSP Rx Capture

  22-01-2026 11:52 via pharmacypracticenews.com
  Originally published by our sister publication Specialty Pharmacy ContinuumBy Gina Shaw Kristen Kissling, PharmD If you don’t have prescription capture, you don’t have an optimally functioning specialty pharmacy, panelists cautioned during a session on technologies transforming health-system specialty pharmacies at the NASP 2025 Annual Meeting & Expo, in Denver.The panelists described how their institutions are leveraging automation, digital tools, and IT partnerships to capture
  
  Read more

• Navigating the Gene Therapy Marketplace

  22-01-2026 11:52 via pharmacypracticenews.com
  Originally published by our sister publication Specialty Pharmacy ContinuumBy Naveed Saleh, MD, MS, and Kate BaggaleyThe unique complexities of the gene therapy marketplace and how health plans can navigate the associated risk assessments and financial considerations were explored in a presentation at AMCP 2025, in Houston.“The probability and timing of gene therapy market entry and its potential price are closely watched by payors because they need to estimate the potential uptake and ana
  
  Read more

Follow @newsl_pharmacy on Twitter!